Described herein are pharmaceutical packaging units which reduce oxidative degradation of morphine, hydromorphone, promethazine and various oxygen-sensitive medications, these kinds of units including a syringe with the oxygen permeable suggestion cap, a hermetically sealed oxygen barrier blister packaging with incredibly reduced permeability to ox